|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0013018,
umls-concept:C0018133,
umls-concept:C0030705,
umls-concept:C0149615,
umls-concept:C0199176,
umls-concept:C0230463,
umls-concept:C0376152,
umls-concept:C0376315,
umls-concept:C0445356,
umls-concept:C0677960,
umls-concept:C1413232,
umls-concept:C1527169
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
2001-2-22
|
|
pubmed:abstractText |
The role of donor marrow T-cell depletion (TCD) in preventing graft-versus-host disease (GVHD) after transplantation of unrelated allogeneic marrow remains undefined. Because different TCD methodologies differ in the degree and specificity with which T cells are removed, it is likely that transplant outcomes would depend on which technique is used. Herein, we report results in the first 48 recipients of unrelated marrow using CD6+ TCD as the sole form of GVHD prophylaxis.
|
|
pubmed:grant |
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Feb
|
|
pubmed:issn |
0732-183X
|
|
pubmed:author |
pubmed-author:AlyeaE PEP,
pubmed-author:AndersonK CKC,
pubmed-author:AntinJ HJH,
pubmed-author:FisherD CDC,
pubmed-author:FreedmanA SAS,
pubmed-author:GribbenJJ,
pubmed-author:LeeSS,
pubmed-author:MarcusKK,
pubmed-author:MauchPP,
pubmed-author:RitzJJ,
pubmed-author:SchlossmanR LRL,
pubmed-author:SoifferR JRJ,
pubmed-author:StoneR MRM,
pubmed-author:WattD MDM,
pubmed-author:WellenII
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
15
|
|
pubmed:volume |
19
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1152-9
|
|
pubmed:dateRevised |
2007-11-14
|
|
pubmed:meshHeading |
pubmed-meshheading:11181681-Adult,
pubmed-meshheading:11181681-Antigens, CD,
pubmed-meshheading:11181681-Antigens, Differentiation, T-Lymphocyte,
pubmed-meshheading:11181681-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:11181681-Bone Marrow Transplantation,
pubmed-meshheading:11181681-Combined Modality Therapy,
pubmed-meshheading:11181681-Female,
pubmed-meshheading:11181681-Graft vs Host Disease,
pubmed-meshheading:11181681-Humans,
pubmed-meshheading:11181681-Leukemia,
pubmed-meshheading:11181681-Lymphocyte Depletion,
pubmed-meshheading:11181681-Lymphocyte Subsets,
pubmed-meshheading:11181681-Male,
pubmed-meshheading:11181681-Middle Aged,
pubmed-meshheading:11181681-T-Lymphocytes
|
|
pubmed:year |
2001
|
|
pubmed:articleTitle |
CD6+ donor marrow T-cell depletion as the sole form of graft-versus-host disease prophylaxis in patients undergoing allogeneic bone marrow transplant from unrelated donors.
|
|
pubmed:affiliation |
Department of Adult Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA. robert_soiffer@dfci.harvard.edu
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, U.S. Gov't, P.H.S.
|
